UM
Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells
Head S.A.; Shi W.; Zhao L.; Gorshkov K.; Pasunooti K.; Chen Y.; Deng Z.; Li R.-J.; Shim J.S.; Tan W.; Hartung T.; Zhang J.; Zhao Y.; Colombini M.; Liu J.O.
2015
Source PublicationProceedings of the National Academy of Sciences of the United States of America
ISSN278424
Volume112Issue:52Pages:E7276
AbstractItraconazole, a clinically used antifungal drug, was found to possess potent antiangiogenic and anticancer activity that is unique among the azole antifungals. Previous mechanistic studies have shown that itraconazole inhibits the mechanistic target of rapamycin (mTOR) signaling pathway, which is known to be a critical regulator of endothelial cell function and angiogenesis. However, the molecular target of itraconazole that mediates this activity has remained unknown. Here we identify the major target of itraconazole in endothelial cells as the mitochondrial protein voltage-dependent anion channel 1(VDAC1), which regulates mitochondrial metabolism by controlling the passage of ions and small metabolites through the outer mitochondrial membrane. VDAC1 knockdown profoundly inhibits mTOR activity and cell proliferation in human umbilical vein cells (HUVEC), uncovering a previously unknown connection between VDAC1 and mTOR. Inhibition of VDAC1 by itraconazole disrupts mitochondrial metabolism, leading to an increase in the cellular AMP:ATP ratio and activation of the AMP-activated protein kinase (AMPK), an upstream regulator of mTOR. VDAC1-knockout cells are resistant to AMPK activation and mTOR inhibition by itraconazole, demonstrating that VDAC1 is the mediator of this activity. In addition, another known VDAC-targeting compound, erastin, also activates AMPK and inhibits mTOR and proliferation in HUVEC. VDAC1 thus represents a novel upstream regulator ofmTOR signaling in endothelial cells and a promising target for the development of angiogenesis inhibitors.
KeywordAngiogenesis Itraconazole Metabolism Mitochondria VDAC1
DOI10.1073/pnas.1512867112
URLView the original
Language英语
The Source to ArticleScopus
Fulltext Access
Citation statistics
Cited Times [WOS]:36   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Recommended Citation
GB/T 7714
Head S.A.,Shi W.,Zhao L.,et al. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells[J]. Proceedings of the National Academy of Sciences of the United States of America,2015,112(52):E7276.
APA Head S.A..,Shi W..,Zhao L..,Gorshkov K..,Pasunooti K..,...&Liu J.O..(2015).Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.Proceedings of the National Academy of Sciences of the United States of America,112(52),E7276.
MLA Head S.A.,et al."Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells".Proceedings of the National Academy of Sciences of the United States of America 112.52(2015):E7276.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Head S.A.]'s Articles
[Shi W.]'s Articles
[Zhao L.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Head S.A.]'s Articles
[Shi W.]'s Articles
[Zhao L.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Head S.A.]'s Articles
[Shi W.]'s Articles
[Zhao L.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.